Sigal Klipstein, MD (InVia Fertility Specialists; University of Chicago)
Judith Daar, JD (Chase College of Law, Northern Kentucky University)
Moderated by: Kimberly Mutcherson, JD (Rutgers Law School)
Abstract: In 2022, the US Supreme Court decision in Dobbs v. Jackson Women’s Health Organization overturned federal protection for abortion. This historic ruling not only relegates this authority to state legislatures but also raises the possibility of restrictions on a range of reproductive technologies. In this panel session, reproductive endocrinologist and infertility specialist Sigal Klipstein and legal scholar and expert on assisted reproductive technologies Judith Daar will discuss the changing regulatory landscape affecting the use of genomics in reproductive health. They will discuss the implications of Dobbs on testing of embryos—including for aneuploidy and single gene disorders, and polygenic disorders and traits—and the jurisprudence surrounding reproductive decision-making. Moderating this forum discussion will be health law and reproductive justice scholar Kim Mutcherson.
ELSI Friday Forum is sponsored by NHGRI
Location and Address
Online